期刊文献+

基因芯片技术及其在医药领域的应用 被引量:9

The Gene Chip Technology and Its Application in the Medicine Area
下载PDF
导出
摘要 基因芯片技术是伴随着人类基因组计划的实施而发展起来的生命科学领域里的前沿生物技术。它最显著的特点是高通量、高集成、微型化、平行化、多样化和自动化。经过短短十几年的发展,基因芯片技术现已在基因表达分析,基因突变及多态性分析,疾病基因诊断,新药设计、药物及毒物基因组学等多个领域显示出重大的理论意义和实际应用价值,具有广阔的前景。本文专门介绍基因芯片技术及其在医药领域的应用。 The gene chip technology is a new biological technique, which was developed accompanying with the human genome project. It fused the achievement of several subjects, such as life science, physics, electronics, computer science and bioinformatics. The advantages of the gene chip technology are high integration, high content, micromation, parallelism, diversification and automatization. This technology has been extensively used in gene expression analysis, detection of gene mutation and gene diversity, disease gene diagnosis, drug design, drug analysis etc and show a very useful applicable foreground. This article introduces the gene chip technology and its application in the medicine area specially.
出处 《中国药事》 CAS 2008年第12期1097-1104,共8页 Chinese Pharmaceutical Affairs
关键词 基因芯片技术 药物 药物基因组学 个体化治疗 gene chip technology medicine pharmacogenomics individual therapy
  • 相关文献

参考文献3

二级参考文献52

  • 1Sougakoff W,Rodrigue C,Truffot-Pemot C,et al.Use of a high -density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis[J].Clin Microbiol Infect 2004,10(1):289-294.
  • 2Head SR,Parikh K,Rogers YH,et al.Solid-phase sequence scanning for drug resistance detection in tuberculosis.Molecular and Cellular Probes 1999,13(1):81-87.
  • 3Zhang Y,Heym B,Allen B,et al.The catalase peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis[J].Nature 1992,358 (2):591-593.
  • 4Wengenack NL,Ul JR,Amand AL,et al.Recombinant Mycobacterium tuberculosis KatG (S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid[J].JID 1997,176(3):722-727.
  • 5[1]Peng XL, Yuan HY, Xie Y, Wang HH. Experimental technique of gene engineering. HuNa Sci Tech Issue Ag Second 1998:197-199
  • 6[2]Xu SH, Mou HZ, Lu GQ, Zhu CH, Yang ZY, Gao YL, Lou HK, Liu XL, Chen Y, Yang W. Gene expression profile difference in high and low metastatic human ovarian cancer cell lines by gene chip. Chin Med J (Engl) 2002; 115:36-41
  • 7[3]Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarra. Gene 1999; 229:101-108
  • 8[4]Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data.Bioinformatics 2000; 16:906-914
  • 9[5]Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, Ochiai K, Takagi T, Nakamura Y. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res 2000; 60:5007-5011
  • 10[6]Zou TT, Selaru FM, Xu Y, Shustova V, Yin J, Mori Y, Shibata D, Sato F, Wang S, Olaru A, Deacu E, Liu TC, Abraham JM, Meltzer SJ. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 2002; 21:4855-4862

共引文献57

同被引文献181

引证文献9

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部